Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 43, Issue 2, 1999, Pages 261-271

  Teo, Peter Man Lung ^a   Chan, Anthony Tak Cheung ^a   Lee, Wai Yee ^a   Leung, Thomas Wai Tong ^a   Johnson, Philip James ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adjunctive; Chemotherapy; Local control; Locally advanced; Node positive; NPC; Radiotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CERVICAL LYMPH NODE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FEMALE; FLUOROURACIL; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; REGRESSION ANALYSIS;

EID: 0033556627     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00383-6     Document Type: Article

References (17)

1. Ho J.H.C. An epidemiologic and clinical study of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 4:1978;183-198.
2. Teo P.M.L., Leung S.F., Yu P., Tsao S.Y., Foo W., Shiu W. Comparison of the Ho's UICC/AJC stage classification for nasopharyngeal carcinoma (NPC). Cancer. 67:1991;434-439.
3. Al-Sarraf M., LeBlanc M., Giri P.G.S., Fu K., Cooper J., Vuong T., Forastiere A., Adams G., Sakr W., Schuller D., Ensley J. Superiority of chemo-radiation vs radiotherapy in patients with locally advanced nasopharyngeal cancer. Preliminary results of intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) randomized study. (Abst.) Proc ASCO. 15:1996;882.
4. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in Stage IV (≥N2, M0) undifferentiated nasopharyngeal carcinoma A positive effect on progression-free survival . Int J Radiat Oncol Biol Phys. 35:(3):1996;463-469.
5. Chan A.T.C., Teo P.M.L., Leung T.W.T., Johnson P.J. Role of chemotherapy in the management of nasopharyngeal carcinoma. Cancer. 82:1998;1003-1012.
6. Teo P.M.L., Leung W.T., Chan A.T.C., Lee W.Y., Leung S.F., Kwan W.H., Johnson P.J. A retrospective study of the use of cisplatin-5-fluorouracil neoadjuvant chemotherapy in cervical-node-positive nasopharyngeal carcinoma (NPC). Eur J Can. 31B:(6):1995;373-379.
7. Chan A.T.C., Teo P.M.L., Leung T.W.T., Leung S.F., Lee W.Y., Yeo W., Choi P., Johnson P.J. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 33:1995;569-577.
8. Al-Sarraf M., McLanglin P.W. Nasopharynx carcinoma Choice of treatment . Int J Radiat Oncol Phys. 33:(3):1995;761-763.
9. Teo P.M.L., Yu P., Lee W.Y., Leung S.F., Kwan W.H., Yu K.H., Choi P.H.K., Johnson P.J. Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int J Radiat Oncol Biol Phys. 36:(2):1996;291-304.
10. Teo P.M.L., Lee W.Y., Yu P. The prognostic significance of parapharyngeal tumour involvement in nasopharyngeal carcinoma. Radiother Oncol. 39:1996;209-221.
11. Teo P.M.L., Kwan W.H., Yu P., Lee W.Y., Leung S.F., Choi P. A retrospective study of the role of intracavitary brachytherapy and prognostic factors determining local tumour control after primary radical radiotherapy in 903 non-disseminated nasopharyngeal carcinoma patients. Clin Oncol. 8:1996;160-166.
12. Al-Sarraf M., LeBlanc M., Giri P.G.S., Fu K.K., Cooper J., Vuong T., Forastiere A.A., Adams G., Sakr W.A., Schuller D.E., Ensley J.F. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer Phase III randomized intergroup study 0099 . J Clin Oncol. 16:(4):1998;1310-1317.
13. Lee A.W.M., Poon Y.F., Foo W., Law S.C.K., Cheung F.K., Chan D.K.K., O S.K., Tung S.Y., Thaw M., Ho J.H.C. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985 Overall survival and patterns of failure . Int J Radiat Oncol Biol Phys. 23:(2):1992;261-270.
14. Sham J.S.T., Choy D. Prognostic factors of nasopharyngeal carcinoma A review of 759 patients . Br J Radiol. 63:1990;51-58.
15. Lee A.W.M., Law S.C.K., Foo W., Poon Y.F., Cheung F.K., Chan D.K.K., O S.K., Tung S.Y., Thaw M., Ho J.H.C. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985 Survival after local recurrence . Int J Radiat Oncol Biol Phys. 26:(5):1993;773-782.
16. Wang C.C. Re-irradiation of recurrent nasopharyngeal carcinoma Treatment techniques and results . Int J Radiat Oncol Biol Phys. 13:1987;953-956.
17. Gueddari BE, (On behalf of the International Nasopharynx Cancer Study Group. Institut Gustave-Roussy Villejuif, France). Final results of the vumca I randomized trial comparing neoadjuvant chemotherapy (CT) (BEC) plus radiotherapy (RT) to RT alone in undifferentiated nasopharyneal carcinoma (UCNT). (Abst.) Proc ASCO 1998;17:1482.